Inspire Medical Systems, Inc.
INSP
$81.79
-$2.02-2.41%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 376.50% | -220.05% | -91.51% | 90.43% | 88.88% |
| Total Depreciation and Amortization | 7.70% | 12.16% | 22.84% | 33.95% | 33.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -35.10% | 48.10% | 8.09% | 8.07% | -13.31% |
| Change in Net Operating Assets | 159.78% | 1.96% | -1,498.04% | -45.33% | 113.67% |
| Cash from Operations | 2,453.13% | 140.04% | -109.69% | 32.32% | 67,129.49% |
| Capital Expenditure | -16.03% | -7.02% | -19.64% | 12.24% | 35.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -102.17% | 710.61% | -36.47% | 111.36% | -627.18% |
| Cash from Investing | -125.01% | 3,098.20% | -141.29% | 103.65% | -1,932.17% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -93.61% | -15.71% | 555.91% | -93.10% | 58.96% |
| Repurchase of Common Stock | -2,869.11% | 98.16% | -32.45% | -1,540.60% | -132.81% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,481.61% | 104.21% | -25.12% | -809.18% | 39.55% |
| Foreign Exchange rate Adjustments | 12.75% | 140.48% | -51.81% | -161.03% | 2,820.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -88.84% | 155.10% | -3,749.28% | 106.51% | -421.13% |